Donald Patrick McDonnell, PhD, has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer.

Researchers in the Department of Obstetrics and Gynecology are examining the silent burden of uterine fibroids. Their push for better medical treatment may give women better, less invasive options—and finally bring fibroid care the attention it deserves.

A close connection to the outdoors led Katelyn Holliday, PhD, to her career as an epidemiologist. Read her advice for aspiring scientists.

A pilot trial finds that delivery of heart-healthy groceries and nutrition education improves blood pressure and reduces food insecurity for people living in underserved communities.

A team of Duke pathologists led by Carolyn Glass, MD, PhD, has been awarded a $1.3 million grant from the National Institutes of Health to conduct the first in-depth study of long COVID’s effect at the tissue level.

An artificial intelligence model developed by Duke Health researchers accurately predicted when adolescents were at high risk for future serious mental health issues before symptoms became severe.

Data reveal a new era of lung cancer surgery—less invasive, more precise, and still life-saving.

The National Institutes of Health's proposal to cap reimbursement of facilities and administrative (F&A) costs on research grants at 15% would significantly slow or cease scientific and biomedical research at Duke and other research institutions. Here is an explanation of what F&A costs are and why they are such a critical piece of the research endeavor.

In recognition of Women's History Month, the School of Medicine highlights just a handful of the women making an impact in the basic sciences.

Thanks to the support of R. Sanders “Sandy” Williams, MD'74, HS'77-'80, and family, a newly-established fund will provide support to laboratory-based research projects conducted by physician-scientists in the School of Medicine.